New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Cytokine mediates obesity-related factors linked to colorectal cancer

Cytokine mediates obesity-related factors linked to colorectal cancer

byMary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersA new study describes the mechanistic relationship between the cytokine interleukin-1ß, (IL-1ß) and obesity, showing that when IL
Oncology December 18,2023
Cytokine mediates obesity-related factors linked to colorectal cancer

Cytokine mediates obesity-related factors linked to colorectal cancer

byMary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersA new study describes the mechanistic relationship between the cytokine interleukin-1ß, (IL-1ß) and obesity, showing that when IL
Oncology December 18,2023
Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati
Oncology December 18,2023
Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati
Oncology December 18,2023
Cancer stem cells use 'normal' genes in abnormal ways

Cancer stem cells use 'normal' genes in abnormal ways

by Garth Sundem,CU Anschutz Medical CampusMayumi Fajita, MD, PhD and colleagues show that CDK1 interacts with Sox2 to keep cancer stem cells 'stemmy'. Credit: University of Colorado Canc
Oncology December 18,2023
Cancer stem cells use 'normal' genes in abnormal ways

Cancer stem cells use 'normal' genes in abnormal ways

by Garth Sundem,CU Anschutz Medical CampusMayumi Fajita, MD, PhD and colleagues show that CDK1 interacts with Sox2 to keep cancer stem cells 'stemmy'. Credit: University of Colorado Canc
Oncology December 18,2023
Lower cancer screening rates differ by region, tied to social vulnerability

Lower cancer screening rates differ by region, tied to social vulnerability

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainPopulations in U.S. counties defined as more vulnerable based on social factors including socioeconomic sta
Oncology December 18,2023
Lower cancer screening rates differ by region, tied to social vulnerability

Lower cancer screening rates differ by region, tied to social vulnerability

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainPopulations in U.S. counties defined as more vulnerable based on social factors including socioeconomic sta
Oncology December 18,2023
Drugs for treating breast cancer in women are effective and well tolerated in men

Drugs for treating breast cancer in women are effective and well tolerated in men

byEuropean Society for Medical OncologyThere is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the la
Oncology December 18,2023
Drugs for treating breast cancer in women are effective and well tolerated in men

Drugs for treating breast cancer in women are effective and well tolerated in men

byEuropean Society for Medical OncologyThere is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the la
Oncology December 18,2023
Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv
Oncology December 18,2023
Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv
Oncology December 18,2023
Cancer screening and detection remain below prepandemic levels

Cancer screening and detection remain below prepandemic levels

At the end of 2021, population-based screening and diagnosis remained below prepandemic levels for breast, cervical, and colorectal cancers, according to a research letter published online Nov. 17 in&
Oncology December 18,2023
Cancer screening and detection remain below prepandemic levels

Cancer screening and detection remain below prepandemic levels

At the end of 2021, population-based screening and diagnosis remained below prepandemic levels for breast, cervical, and colorectal cancers, according to a research letter published online Nov. 17 in&
Oncology December 18,2023
Chemotherapy drug paclitaxel also acts as an immune response modulator

Chemotherapy drug paclitaxel also acts as an immune response modulator

by Maria Fernanda Ziegler,FAPESPBy finding that the cancer drug also activates a key cellular receptor in the innate immune system, a study at the Center for Research in Inflammatory Diseases (C
Breakthroughs December 18,2023
Chemotherapy drug paclitaxel also acts as an immune response modulator

Chemotherapy drug paclitaxel also acts as an immune response modulator

by Maria Fernanda Ziegler,FAPESPBy finding that the cancer drug also activates a key cellular receptor in the innate immune system, a study at the Center for Research in Inflammatory Diseases (C
Breakthroughs December 18,2023
Anti-inflammatory drug effective for treating lymphedema symptoms

Anti-inflammatory drug effective for treating lymphedema symptoms

byStanford University Medical CenterHuman skin structure. Credit: WikipediaFor more than three decades, Lisa Hanson did her best to hide the unsightly fluid retention in her left leg that caused
World medicine December 18,2023
Anti-inflammatory drug effective for treating lymphedema symptoms

Anti-inflammatory drug effective for treating lymphedema symptoms

byStanford University Medical CenterHuman skin structure. Credit: WikipediaFor more than three decades, Lisa Hanson did her best to hide the unsightly fluid retention in her left leg that caused
World medicine December 18,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com